Deblina Raychaudhuri retweeted
🎬 That’s a wrap! #ANRF Research Impact Conclave @AshokaUniv 150+ participants, 30+ grantees! Great insights from Prof. @karandi65 Dr. @shivkuma_k, a fun #SaralAI session + lab visit. 🙏🏽 Ashoka team! Great catching up with Profs. @DheerajSanghi, Lipika & @laks316 #ANRFSabbatical
Deblina Raychaudhuri retweeted
Sad to see misinformation circulating regarding HPV vaccination on social media. Clinical trials show that HPV vaccines provide close to 100% protection against cervical pre-cancers. Its inclusion in national programmes is a consistent recommendation from experts. @MoHFW_INDIA
Deblina Raychaudhuri retweeted
First edition of Himalayan Symposium on Immunology, supported by Datla Human Immunome Lab & Trivedi School of Biosciences, @AshokaUniv, was held in Darjeeling, bringing global experts to discuss advanced immunology.
HSI 2025 will continue as an annual event promoting immunology.
If you are interested in research in the field of tumor immunology and epigenetics, I am actively looking to recruit PhD students to join my lab at Ashoka University (ashoka.edu.in/profile/deblin…).
Application deadline: 20th November 2025
Deblina Raychaudhuri retweeted
Students pursuing their Master’s degree with a strong academic background and a special interest in immunology are encouraged to apply.
Register Now: ashoka.edu.in/event/global-i…
Application Deadline: 15 October, 2025
#AshokaUniversity
Deblina Raychaudhuri retweeted
Surgery enhances immunotherapy in advanced kidney cancer | MD Anderson Cancer Center @MDAndersonNews @KidneyCancer mdanderson.org/newsroom/rese…
Congratulations @SGoswamiMDPhD!🍾 🥂
nature.com/articles/s41467-0…
Deblina Raychaudhuri retweeted
Next-generation sequencing and immunotherapy give bladder cancer patient hope | MD Anderson Cancer Center mdanderson.org/cancerwise/ne…
Deblina Raychaudhuri retweeted
One of the best review writing experiences with @kepauken@IamLinghua, @PamSharmaMDPhD
Thanks for the invitation @NatImmunol
Next-generation combination approaches for immune checkpoint therapy | @MDAndersonNews
nature.com/articles/s41590-0…
Deblina Raychaudhuri retweeted
Thank you @ScienceMagazine for highlighting our recent manuscript in @NatImmunol (Nat. Immunol. (2024) 10.1038/s41590-024-01985-9) in your research highlight section. @DeblinaRC @PSingh_PhD @MDAndersonNews
Deblina Raychaudhuri retweeted
The course, New Perspectives in the Front-line Treatment of Metastatic Bladder Cancer, offers the opportunity to obtain 4.5 free CME credits/MOC points while completing brief learning modules via Zoom. You can learn more and sign up at:medicallogix.gathered.com/in…
Deblina Raychaudhuri retweeted
Ashoka University invites applications from Master's students with a keen interest in immunology to participate in the Global Immunocourse to be hosted at Ashoka University from December 13 to December 22, 2024. The Global Immunocourse is designed to provide a comprehensive introduction to the foundational knowledge of immunology. It offers a unique opportunity for aspiring immunologists to engage in discussions with leading experts in the field, gaining insights into cutting-edge research and developments. Students pursuing their Master’s degree with a strong academic background and a special interest in immunology are encouraged to apply.
For more information and to apply - ashoka.edu.in/event/global-i…
#AshokaUniversity
Deblina Raychaudhuri retweeted
Understanding histone lactylation to enhance immunotherapy. Amazing work by @SGoswamiMDPhD in Nat Immunology! @MDAndersonNews acir.org/weekly-digests/2024…
Deblina Raychaudhuri retweeted
Metabolic–epigenetic rewiring in CD8+ T cells via lactate-dependent histone lactylation | Nature Immunology
Thanks @hongbo_chi for the News and Views on our article. @NatImmunol @MDAndersonNews nature.com/articles/s41590-0…
Deblina Raychaudhuri retweeted
Replying to @ACIR_org
@ACIR_org, thank you for featuring our manuscript on the role of histone lactylation in CD8 T cell effector function. @NatImmunol @MDAndersonNews @DeblinaRC @PSingh_PhD @jmancuso76 #JPAI
Raychaudhuri and Singh et al. dug into the relationships between metabolism, histone lactylation, and T cell functionality to better understand mechanisms that could be exploited for immunotherapy bit.ly/4fcRFmC @DeblinaRC @PSingh_PhD @MDAndersonNews @SGoswamiMDPhD
Deblina Raychaudhuri retweeted
Congratulations!! Deblina & her super mentor Sangeeta @SGoswamiMDPhD . Just wrapped a fantastic day at #JAI symposium today @MDAndersonNews. Sincere thanks to organizers and all moderators @Aiims1742 @BettyKimLab @PamSharmaMDPhD @JimAllisonPhD
This quoted post is unavailable.
Thank you so so much @SGoswamiMDPhD! None of this would have been possible without you. Goswami_Lab rocks!! @PSingh_PhD @Bchakraborty99 @amounajt @swadhinkmeher
unavailable
Deblina Raychaudhuri retweeted
Dr. @DeblinaRC, Pratishtha Singh, @SGoswamiMDPhD, and team show the enrichment of H3K18 lactylation and H3K9 lactylation in human and mouse CD8+ T cells, which act as transcription initiators of key genes regulating CD8+ T cell function.
👉 go.nature.com/481kqA9
Deblina Raychaudhuri retweeted
H3K18 & H3K9 lactylation in CD8+ T cells initiates transcription of key genes regulating function and can be targeted to modulate antitumor immunity @NatImmunol @SGoswamiMDPhD @DeblinaRC
@RaiPratishtha
nature.com/articles/s41590-0…






















